• Home
  • Search Results

Search Results

2545 studies match your search
Not currently enrolling

Personalized vaccine with pembrolizumab for patients with non-small cell lung cancer or squamous cell cancer of the head and neck

In this study, we want to learn more about the safety and effectiveness of using a personalized vaccine with a drug called pembrolizumab for the treatment of non‐small cell lung cancer (NSCLC) and squamous cell cancer of the head and neck (SCCHN).

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Head and Neck, Lung)
Not currently enrolling

Physical Activity for Adults with Intellectual Disability

We are doing a study to help us adapt a physical activity program for adults with intellectual disabilities. We are looking for adults with intellectual disabilities, parents/caregivers, support staff, and exercise professionals to complete a survey and take part in interviews or focus groups to provide feedback on a physical activity program. The program includes weekly group fitness meetings, one-to-one coaching meetings, and an app to support setting, monitoring, and achieving exercise goals.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Behavior
  • Obesity
  • Movement
  • and 2 more

Pilot Study of Abequolixron (RGX-104) and Durvalumab in Lung Cancer

The purpose of this study is to investigate the effects of using durvalumab plus platinum doublet chemotherapy (carboplatin/abraxane or carboplatin/pemetrexed) with or without abequolixron (RGX-104) in patients with non-small cell lung cancer (NSCLC) before surgery.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Lung)
Open

Phase II Study of Trilaciclib and Lurbinectidin

Have you been diagnosed with small cell lung cancer? Is your current treatment no longer working in controlling your cancer? If so, you may be able to take part in a research study looking at giving trilaciclib to help minimize the side effects of lurbinectedin.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Lung)
  • Lungs and Breathing
Open

EAGLE: Efficacy Assessment in recurrent wheezing children

Does your child have recurrent wheezing? They may be able to take part in the EAGLE study to help us learn if a new medication may help.

Age & Gender
  • 6 months ~ 5 years
  • Male, Female, Gender Inclusive
Study Interest
  • Allergy
  • Immune System/Infections
  • Parents of Children
  • and 2 more
Open

A randomized open label trial examining the effectiveness of Ofatumumab versus current therapy on relapsing multiple sclerosis.

Are you between 18 and 45 years of age and diagnosed with multiple sclerosis, without MS relapses within the past year? Are you currently prescribed with MS medication? If so, you may be able to participate in a research study examining whether a switch to a high-efficacy medication- Ofatumumab, would work better for you than your current treatment.

Age & Gender
  • 18 years ~ 45 years
  • Male, Female, Gender Inclusive
Study Interest
  • Chronic Conditions
  • Immune System/Infections
Not currently enrolling

TEMPO

TEMPO stands for Time restricted Eating for Metabolic and Psychological Optimization. We are examining whether changing the timing of regular eating behaviors can improve memory and brain function among adults with memory problems.

Age & Gender
  • 65 years ~ 80 years
  • Male, Female, Gender Inclusive
Study Interest
  • Aging
  • Chronic Conditions
  • Eating, Nutrition, and Metabolism
  • and 4 more
Not currently enrolling

Eye-tracking study of people who both smoke and vape

We are doing a research study of people who both smoke and vape. The purpose of this study is to learn more about your opinions on health messages.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Substance Use (tobacco, alcohol, opioids, etc)
Visit Location
Open

Walking Training for Parkinson disease

People with Parkinson disease often develop difficulty walking. Metronomes are thought to help improve walking. We believe that setting metronomes slower while walking on a treadmill and faster when walking over the ground may target certain portions of gait. Our goal is to create beneficial changes in the way that people walk that persist and can be seen in the long-term.

Age & Gender
  • 50 years ~ 80 years
  • Male, Female, Gender Inclusive
Study Interest
  • Physical Disability
  • Movement

PRO-VISION: Patient Reported Outcomes-Based Monitoring of VEGF-Inhibitor Side Effects in Oncology

This is a research study to investigate how collecting information about treatment-related side effects directly from patients can help manage the side effects associated with certain oral chemotherapies in patients with metastatic renal cell carcinoma.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Kidney)
Visit Location
Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research